Ujjal K. Mallick

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

Ujjal K. Mallick, Clive Harmer, B. Yap et al. · New England Journal of Medicine · 2012 · 606 citations · Full text

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

Hakim‐Moulay Dehbi, Ujjal K. Mallick, Jonathan Wadsley et al. · The Lancet Diabetes & Endocrinology · 2018 · 136 citations · Full text

Pilot of <i><scp>BRAF</scp></i> mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology

Samantha Johnson, Steven Hardy, Catherine C. Roberts et al. · Cytopathology · 2014 · 38 citations

Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer

Martin L. Read, Jim C. Fong, Bhavin Modasia et al. · Oncogene · 2017 · 32 citations · Full text

Medicine, Genetics, Thyroid Disease +9

Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma

David R. Weightman, Ujjal K. Mallick, John D. Fenwick et al. · Cancer · 2003 · 31 citations · Full text